West Pharmaceu…
ProfileJobs

West Pharmaceutical Services

Suggest Edit
    • Healthbiotechpackagingpharma
    West Pharmaceutical Services manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally. The Company's Proprietary Products segment offers stoppers and seals for injectable packaging systems and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. This segment serves biologic, generic, and pharmaceutical drug companies. Its Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. West Pharmaceutical Services distributes products through its sales force and distribution network, as well as contract sales agents and regional distributors.
    Show more
    Revenue(FY, 2016)
    $1.5 B
    Market capitalization(2018-06-22)
    $7.4 B
    Type
    Public
    HQ
    Exton, US
    Founded
    1923
    Size (employees)
    7,300 (est)
    Website
    westpharma.com
    West Pharmaceutical Services was founded in 1923 and is headquartered in Exton, US
    Report incorrect company information

    West Pharmaceutical Services Office Locations

    West Pharmaceutical Services has an office in Exton
    Exton, US (HQ)
    530 Herman O. W Dr
    Show all (1)
    Report incorrect company information

    West Pharmaceutical Services Financials and Metrics

    West Pharmaceutical Services Financials

    West Pharmaceutical Services's revenue was reported to be $1.51 b in FY, 2016 which is a 7.8% increase from the previous period.
    USD

    Revenue (Q3, 2017)

    		398.2 m

    Net income (Q3, 2017)

    		51 m

    EBIT (Q3, 2017)

    		63.9 m

    Market capitalization (22-Jun-2018)

    		7.4 b

    Closing share price (22-Jun-2018)

    		101
    West Pharmaceutical Services's current market capitalization is $7.4 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Revenue

    		1.4 b1.4 b1.4 b1.5 b

    Revenue growth, %

    		4%(2%)8%

    General and administrative expense

    		239.8 m

    R&D expense

    		36.8 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    		341.8 m346.8 m368.9 m355.9 m335.9 m359.7 m344.5 m362.1 m388 m376.7 m387.7 m397.6 m398.2 m

    General and administrative expense

    		56.1 m56.4 m57.5 m56 m55.2 m60.8 m54.6 m58.1 m62.5 m58.3 m61.6 m60.6 m61.5 m

    R&D expense

    		9.6 m10 m9.9 m9.6 m7.5 m8.1 m8.5 m9.4 m8.8 m9 m10.3 m10 m9.1 m

    Operating expense total

    		65.7 m66.4 m67.4 m65.6 m62.7 m68.9 m63.1 m67.5 m71.3 m67.3 m71.9 m70.6 m70.6 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    		230 m255.3 m274.6 m203 m

    Accounts Receivable

    		185.7 m179 m181.4 m200.5 m

    Inventories

    		176.9 m181.5 m181.1 m199.3 m

    Current Assets

    		650.7 m659.3 m673.7 m641.9 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

    Cash

    		221.7 m230 m226.7 m246.8 m207.1 m252 m256.8 m178.1 m202.7 m205.9 m169.4 m226.6 m269.3 m

    Accounts Receivable

    		198.2 m208.7 m209.6 m195.9 m189.5 m198.8 m194.6 m209.6 m219 m209.5 m224.8 m242.4 m251.8 m

    Inventories

    		176.7 m187.5 m187.9 m185.7 m183.4 m187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m211.3 m215.8 m

    Current Assets

    		643.5 m686.6 m685.4 m679.5 m625.1 m679.9 m680.9 m630.7 m659.2 m658.1 m652.6 m717.8 m776.9 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    		112.3 m127.1 m95.6 m143.6 m

    Depreciation and Amortization

    		81 m84.8 m86.1 m88.1 m

    Inventories

    		(14 m)(16 m)(11 m)(21.2 m)

    Accounts Payable

    		4.6 m(3.5 m)17.2 m6.1 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

    Net Income

    		26.8 m27.1 m37.6 m31 m32.9 m60.7 m62.2 m22.1 m66.9 m104.5 m60.9 m99.7 m150.7 m

    Inventories

    		187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m

    Accounts Payable

    		91.4 m93.6 m97.5 m107.3 m99 m106.1 m

    Cash From Operating Activities

    		45 m
    show all
    Show all financial metrics
    Report incorrect company information

    Competitors

    NovaBay Pharmaceuticals
    Health - Public
    Chiasma
    Health - Public
    LGC Biosearch Technologies
    Health - Subsidiary
    Verona Pharma
    Health - Public
    Compare competitors

    West Pharmaceutical Services Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    West Pharmaceutical Services News and Updates

    April 26, 2018

    West Pharmaceutical Services' (WST) CEO Eric Green on Q1 2018 Results - Earnings Call Transcript

    April 26, 2018

    West Pharmaceutical Services Inc. 2018 Q1 - Results - Earnings Call Slides

    January 10, 2018

    Global Pharmaceutical Vial Market 2018 Key Players: Gerreshemier AG, Schott AG, West Pharmaceutical Services, Inc., Berk Company LLC, Piramal Glass Limited, Nipro Europe,.

    WiseGuyReports.com adds “Pharmaceutical Vial Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF